AlenCiken

significantly improved symptoms of depression

NASDAQ:AXSM   Axsome Therapeutics, Inc.
significantly improved symptoms of depression in the ASCEND Phase 2 trial in major depressive disorder (MDD)

finance.yahoo.c...-110000906.html?.tsrc=rss

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.